- HK$1.87bn
- HK$2.44bn
- HK$1.57bn
Brief: Jacobson Pharma Says Lenders To Provide Syndicated Loan To Unit In Facility Amount Of HK$1.4 Bln
Brief: Jacobson Pharma Says Chairman/CEO, Through Controlled Entity Acquired 20.5 Mln Shares Of Co
Brief: Jacobson Pharma Corp Posts HY Profit Of HK$82.9 Million
Brief: Jacobson Pharma Corp Says Profit Attributable For Year HK$173.7 Million
Chinese medicines distributor JBM surges in Hong Kong debut
Brief: Jacobson Pharma Corp Updates On Proposed Spin-Off & Separate Listing Of JBM (Healthcare)
Brief: Jacobson Pharma Corp Says HY Revenue Fell 8.2%
HK-listed Jacobson Pharma jumps as plan to spinoff healthcare unit approved
Brief: Jacobson Pharma Corp Proposes To Spin-Off Branded Healthcare Business Of Group
Brief: Jacobson Pharma Corp Says Co And Fosun Industrial Co. Entered Letter Of Intent
Brief: Shanghai Fosun Pharma's Unit Signs Letter Of Intent With Jacobson Pharma On Supply And Distribution Of mRNA Coronavirus Vaccine In Hong Kong And Macau
Brief: Jacobson Pharma Corp Unit To Acquire 10% Of Total Issued Share Capital In Orizen Capital Ltd
Brief: Jacobson Pharma FY Profit Attributable HK$215.6 Mln, Down 13.9%
Brief: Jacobson Pharma Corp Says Milion Effort Investment To Purchase 49% Stake In Hong Ning Hong
HK's Jacobson Pharma at near 16-mths high on new product launch
Brief: Jacobson Pharma's Unit Launched A Home Diagnostic Product In Hong Kong & Macau
Brief: Jacobson Pharma Proposes To Spin-Off And Seek Separate Listing Of Branded Healthcare Business
Brief: Jacobson Pharma Corp Says Pharma Group To Buy Rexway Group For Hk$7.8 Mln
Brief: Jacobson Pharma Corp Recommends Payment Of Interim Dividend Of HK2.0 Cents Per Ordinary Share